The FDA approves 23andMe's gene test for cancer

The FDA approves 23andMe's gene test for cancer  Pittsburgh Post-Gazette 23andMe gets FDA approval to report breast cancer risk without a doctor  The Mercury News FDA OKs 23andMe home breast cancer DNA test, with warning  NBCNews.com The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. - NCBI  NCBI FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer ...  FDA.govFull coverage

Read More ...
The FDA approves 23andMe's gene test for cancer published March 07, 2018 at 02:05PM. Original Source Link : http://www.post-gazette.com/news/health/2018/03/07/The-FDA-approves-23andMe-s-gene-test-for-cancer/stories/201803060198

loading...